BD today continues to focus on a proven strategy: driving growth
through innovation, and expanding margins by improving operating
effectiveness. Delivering ever more innovative solutions to the global
healthcare community drives the top line. A relentless dedication to
operational effectiveness delivers on the bottom line. Working together,
these two essential elements of our strategy drive our performance.
At BD, a constant focus on the customerfrom the individual
patient to clinicians, researchers, pharmaceutical companies and
government agenciesis the factor creating that synergy. For BD
associates, regardless of geography or function, keeping customer
needs first and foremost is the means of fulfilling the Company's
vision of taking healthcare from where it is in the present and elevating
it to higher levels in the future.
Along with a focus on the customer, two additional attributes
help BD make higher-value contributions to global health. The
first is BD's drive and desire for continuous improvement. BD is
a company that will make repeated incremental improvements
whose net effect over time adds up to dramatic advances, as evidenced
by the many significant innovations in our 108-year history.
The second is the passion that BD associates bring to their
work. Says Jim Brown, Vice President, Quality Management:
"People are excited about doing new things, and there is a level
of energy and passion in the Company today that creates a
wonderful atmosphere."
Knowing the customer makes a difference
BD's close working relationship with Dr. Frederic Preffer, profiled
here, dates back more than 20 years and brings to life how BD's
focus on the customer materially impacts medical science. "The
flow cytometers BD is providing at the Center for Regenerative
Medicine and Harvard Stem Cell Research Institute put BD in the
first row of cutting edge science," Dr. Preffer says, adding, "The
Company is an asset to us with its many technical resources and
scientific expertisenot only in instrumentation, but also in reagents,
which my experience has convinced me are the best available."
BD's customer focus permeates the entire Company. A
customer-driven perspective on the part of sales and marketing
associates may not be unusual, but a strong customer orientation
in manufacturing, distribution, information technology, regulatory
affairs and similar functions is. Commenting on the BD Operational
Effectiveness Task Force (see pages 2-3), David Malpiedi, Vice
President, Global Business Processes, says, "Typically, people think of
operational effectiveness as an inwardly-focused initiative. Actually,
every conversation among Task Force members starts and ends with
the customer and ways of continually elevating service and quality
levels so that we routinely delight all of our customers."
|
 |
Frederic Preffer, Ph.D., is a rare example of an expert in flow cytometry who is recognized
for contributions to both clinical practice and medical research. His Clinical Flow Cytometry
Laboratory in the Department of Pathology at Massachusetts General Hospital aids in
the diagnosis of leukemia, lymphoma and other serious hematopoietic diseases. At the
Center for Regenerative Medicine, closely affiliated with the Harvard Stem Cell Institute,
Dr. Preffer researches promising cell-based therapies, but realizes that breakthroughs
may take years to develop. In his clinical lab, rewards can come daily. "Our pediatric
hemato-oncologists have worked miracles," he says, "in part because our lab delivers
incredibly fast, accurate diagnoses." In the research setting, he relies on special order
BD flow cytometers. BD Biosciences' Larry Duckett has collaborated with Dr. Preffer on
an 18-color, 20-parameter BD LSR II Flow Cytometer, noting, "Applying BD's technology
to help solve real world medical issues is extremely rewarding." William Rhodes,
VP/GM BD Biosciences Cell Analysis, says, "R&D teams designed a sophisticated yet
flexible platform that enables further customization for very specific research needs."

The BD LSR II Flow Cytometer is an extremely flexible,
powerful benchtop analyzer. Its innovative optics and
digital electronics create a highly sensitive instrument
that yields more information from each sample. Reliability
is another plus, as these flow cytometers have minimal
downtime without requiring additional support beyond
routine maintenance. The flexible architecture also
provides an ideal platform for building even more powerful
instruments. To meet customers' expanding and
increasingly sophisticated needs, BD is extending its
special order capabilities to include additional analyzers
and cell sorters.
|
|
 |